Biocellular-Cellular Regenerative Treatment Scarring Alopecia and Alopecia Areata (SAAA)
Biocellular Regenerative Therapy in Treating Scaring Alopecias and Alopecia Areata: Use of High Density Platelet-Rich Plasma Concentrates and Cell-Enriched Emulsified Adipose-Derived Tissue Stromal Vascular Fraction (AD-tSVF)
Researchers in CA, MA, and MT are recruiting patients with allopecia to trial an investigatory regenerative cell therapy utilizing adipose-derived (from the fat tissue) stem cells and tissues in combination with plasma concentrate made from the blood. Depending on the portion of the study assigned, a combination of one or several of these will be infused intravenously, and hair growth assessment will be followed up for ~12 months.
- Be 18 to 75 years of age
- Have a biopsy proven diagnosis of a Scarring alopecia (SA) or Alopecia Areata (AA)
- Willing to consent to fetal autopsy in the event of a fetal demise
THE STUDY INVOLVES:
- Prescreening tests to confirm eligibility of the patient to participate.
- Liposuction recovery of adipose aspirate for cellular and tissue stromal vascular fraction, along with plasma draw and concentration. There will be lab prep time for these components.
- Infusion intravenously of the components (one or several, depending on the study group to which the patient is assigned).
- Follow up will continue with physical assessments ~12 months after treatment.
LOCATIONS AND CONTACTS:
Ryan Welter, MD, PhD | 508.345.5492 | [email protected]
Ken Williams, DO | 1.949.333.2999 | [email protected]
Global Alliance for Regenerative Medicine
Or go online: